Stockholm - Delayed Quote SEK
Fluicell AB (publ) (FLUI.ST)
At close: 5:21 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-25,148.0000
-27,227.0000
-21,043.0000
-18,640.0000
-17,569.0000
Investing Cash Flow
198.0000
--
-1,136.0000
-772.0000
-331.0000
Financing Cash Flow
32,249.0000
5,533.0000
25,942.0000
21,306.0000
28,263.0000
End Cash Position
21,686.0000
2,763.0000
24,457.0000
20,694.0000
18,800.0000
Capital Expenditure
--
--
-1,136.0000
-772.0000
-331.0000
Issuance of Capital Stock
39,337.0000
3,871.0000
31,664.0000
23,202.0000
37,189.0000
Repayment of Debt
--
--
--
--
-5,000.0000
Free Cash Flow
-24,950.0000
-27,227.0000
-22,179.0000
-19,412.0000
-17,900.0000
12/31/2020 - 4/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATORX.ST Alligator Bioscience AB (publ)
0.6620
-8.06%
ACE.ST Ascelia Pharma AB (publ)
2.0850
-2.57%
COMBI.ST CombiGene AB (publ)
2.6600
+3.91%
ELIC-TO2.ST Elicera Therapeutics AB
0.3980
-11.95%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1688
+4.20%
ATORX-TO-9.ST Alligator Bioscience AB
0.0750
-40.24%
SPRINT.ST Sprint Bioscience AB (publ)
2.0100
+4.91%
CYXO.ST Cyxone AB (publ)
0.0320
-4.48%
ELIC.ST Elicera Therapeutics AB (publ)
1.9050
-3.54%
ACOU.ST AcouSort AB (publ)
13.45
-3.58%